1. Home
  2. EYEN

EYEN

Eyenovia Inc.

Logo Eyenovia Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

Founded: 2014 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 25.6M IPO Year: 2018
Target Price: $10.00 AVG Volume (30 days): 1.2M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.66 EPS Growth: N/A
52 Week Low/High: $0.50 - $5.85 Next Earning Date: 05-09-2024
Revenue: $3,787 Revenue Growth: N/A
Revenue Growth (this year): 140882.31% Revenue Growth (next year): 149.56%

Share on Social Networks:

Stock Insider Trading Activity of Eyenovia Inc. (EYEN)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Grant Stuart M. EYEN 10% Owner Mar 28 '24 Buy $0.98 100,000 $98,000.00 5,430,715 SEC Form 4
Grant Stuart M. EYEN 10% Owner Mar 19 '24 Buy $1.23 50,000 $61,500.00 5,330,715 SEC Form 4